EFFECTS OF TAUROURSODEOXYCHOLIC ACID ON CYTOSOLIC CA2+ SIGNALS IN ISOLATED RAT HEPATOCYTES

被引:120
作者
BEUERS, U [1 ]
NATHANSON, MH [1 ]
BOYER, JL [1 ]
机构
[1] YALE UNIV, SCH MED, DEPT INTERNAL MED, NEW HAVEN, CT 06510 USA
关键词
D O I
10.1016/0016-5085(93)90433-D
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Tauroursodeoxycholic acid (TUDCA) is of potential benefit in cholestatic disorders. However, the effects of TUDCA on cytosolic free calcium [(Ca2+)i], which regulates hepatocyte secretion, are unknown. Methods: The effect of TUDCA on (Ca2+)i was investigated in groups of isolated rat hepatocytes by microspectrofluorometry and in single cells by confocal line scanning microscopy. Results: Administration of TUDCA (5-50 μmol/L) induced a nearly fourfold increase of basal levels of (Ca2+)i. After a 15 minute treatment period, the TUDCA (10 μmol/L)-induced change in (Ca2+)i was higher than that of other monodi-, and trihydroxy bile acids at equimolar concentrations. Pretreatment with TUDCA (10 μmol/L) markedly reduced or abolished increases in (Ca2+)i induced by phenylephrine (1 μmol/L), the microsomal Ca2+ translocase inhibitor 2,5-di-(tert-butyl)-1,4-benzohydroquinone (25 μmol/L), or taurolithocholic acid (10-25 μmol/L). In Ca2+-free medium, TUDCA caused only a reduced and transient increase in (Ca2+)i. TUDCA (10 μmol/L) induced Ca2+ oscillations in all single cells that responded. However, levels of inositol-1,4,5-trisphosphate (IP3) in hepatocytes were not increased by treatment with TUDCA (10 μmol/L). Conclusions: TUDCA at physiological concentrations potently modulates (Ca2+)i signals in hepatocytes by (1) mobilizing microsomal IP3-sensitive Ca2+ stores by an IP3-independent mechanism, (2) initiating Ca2+ oscillations, and (3) inducing influx of extracellular Ca2+. © 1993.
引用
收藏
页码:604 / 612
页数:9
相关论文
共 47 条
  • [1] ANWER MS, 1989, P SOC EXP BIOL MED, V191, P147
  • [2] HEPATOTOXIC BILE-ACIDS INCREASE CYTOSOLIC CA++ ACTIVITY OF ISOLATED RAT HEPATOCYTES
    ANWER, MS
    ENGELKING, LR
    NOLAN, K
    SULLIVAN, D
    ZIMNIAK, P
    LESTER, R
    [J]. HEPATOLOGY, 1988, 8 (04) : 887 - 891
  • [3] EFFECT OF URSODEOXYCHOLIC ACID ON BILE-ACID METABOLISM IN PRIMARY BILIARY-CIRRHOSIS
    BATTA, AK
    SALEN, G
    ARORA, R
    SHEFER, S
    TINT, GS
    ABROON, J
    ESKREIS, D
    KATZ, S
    [J]. HEPATOLOGY, 1989, 10 (04) : 414 - 419
  • [4] TAUROURSODEOXYCHOLIC ACID INHIBITS THE CYTOSOLIC CA++ INCREASE IN HUMAN NEUTROPHILS STIMULATED BY FORMYL-METHIONYL-LEUCYL-PHENYLALANINE
    BEUERS, U
    THIEL, M
    BARDENHEUER, H
    PAUMGARTNER, G
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 171 (03) : 1115 - 1121
  • [5] URSODEOXYCHOLIC ACID FOR TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS - A PLACEBO-CONTROLLED TRIAL
    BEUERS, U
    SPENGLER, U
    KRUIS, W
    AYDEMIR, U
    WIEBECKE, B
    HELDWEIN, W
    WEINZIERL, M
    PAPE, GR
    SAUERBRUCH, T
    PAUMGARTNER, G
    [J]. HEPATOLOGY, 1992, 16 (03) : 707 - 714
  • [6] FORMATION OF ISO-URSODEOXYCHOLIC ACID DURING ADMINISTRATION OF URSODEOXYCHOLIC ACID IN MAN
    BEUERS, U
    FISCHER, S
    SPENGLER, U
    PAUMGARTNER, G
    [J]. JOURNAL OF HEPATOLOGY, 1991, 13 (01) : 97 - 103
  • [7] EFFECT OF URSODEOXYCHOLIC ACID ON THE KINETICS OF THE MAJOR HYDROPHOBIC BILE-ACIDS IN HEALTH AND IN CHRONIC CHOLESTATIC LIVER-DISEASE
    BEUERS, U
    SPENGLER, U
    ZWIEBEL, FM
    PAULETZKI, J
    FISCHER, S
    PAUMGARTNER, G
    [J]. HEPATOLOGY, 1992, 15 (04) : 603 - 608
  • [8] BOUSCAREL B, 1991, GASTROENTEROLOGY, V101, pA723
  • [9] CAPIOD T, 1991, J BIOL CHEM, V266, P268
  • [10] COMBETTES L, 1989, J BIOL CHEM, V264, P157